X0508 4 2024-02-16 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001973240 White Mark Andrew C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true Chief Medical Officer false Common Stock 2024-02-16 4 A 0 11096 0 A 87758 D Stock Option (Right to Buy) 30.01 2024-02-16 4 A 0 32727 0 A 2034-02-16 Common Stock 32727 32727 D Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years. This option represents a right to purchase a total of 32,727 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. /s/ Martin Wilson, as attorney-in-fact for Mark Andrew White 2024-02-21